Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2109293rdf:typepubmed:Citationlld:pubmed
pubmed-article:2109293lifeskim:mentionsumls-concept:C0043210lld:lifeskim
pubmed-article:2109293lifeskim:mentionsumls-concept:C0018067lld:lifeskim
pubmed-article:2109293lifeskim:mentionsumls-concept:C0018061lld:lifeskim
pubmed-article:2109293lifeskim:mentionsumls-concept:C0205065lld:lifeskim
pubmed-article:2109293lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:2109293lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:2109293lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:2109293lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:2109293lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:2109293lifeskim:mentionsumls-concept:C0205228lld:lifeskim
pubmed-article:2109293lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:2109293pubmed:issue5lld:pubmed
pubmed-article:2109293pubmed:dateCreated1990-5-18lld:pubmed
pubmed-article:2109293pubmed:abstractTextFailure to respond to human menopausal gonadotropin (hMG) with adequate ovarian stimulation is associated with a poor prognosis in subsequent cycles in women participating in an in vitro fertilization/embryo transfer program. Sera from 26 menstruating women (mean age 38 +/- 4.3 years) identified as "low responders" with either tubal or male factor infertility, mean baseline FSH values of 11 mIU/mL, and peak serum estradiol levels lower than 300 pg/mL were assessed for specific antibodies to human ovary and gonadotropins. Twenty-five infertile women with tubal or male factor infertility with a good response to hMG served as controls. Ninety-two percent of low responders had antibodies to FSH and 65% had antibodies to LH when assessed by enzyme-linked immunosorbent assay. Similarly, 77% of low responders had ovarian antibodies. No hepatic antibodies were found in the sera of low responders, indicating that the positivity was not a general interaction with cell components. None of the "good responders" had antibodies to gonadotropins or to ovarian or liver tissue. The significant differences in antibodies between the groups supports a possible immunologic cause for low ovarian stimulation response to gonadotropin.lld:pubmed
pubmed-article:2109293pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2109293pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2109293pubmed:languageenglld:pubmed
pubmed-article:2109293pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2109293pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2109293pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2109293pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2109293pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2109293pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2109293pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2109293pubmed:statusMEDLINElld:pubmed
pubmed-article:2109293pubmed:monthMaylld:pubmed
pubmed-article:2109293pubmed:issn0029-7844lld:pubmed
pubmed-article:2109293pubmed:authorpubmed-author:LuborskyJ LJLlld:pubmed
pubmed-article:2109293pubmed:authorpubmed-author:DeCherneyA...lld:pubmed
pubmed-article:2109293pubmed:authorpubmed-author:LavyGGlld:pubmed
pubmed-article:2109293pubmed:authorpubmed-author:MeyerW RWRlld:pubmed
pubmed-article:2109293pubmed:authorpubmed-author:VisintinIIlld:pubmed
pubmed-article:2109293pubmed:authorpubmed-author:EconomyKKlld:pubmed
pubmed-article:2109293pubmed:issnTypePrintlld:pubmed
pubmed-article:2109293pubmed:volume75lld:pubmed
pubmed-article:2109293pubmed:ownerNLMlld:pubmed
pubmed-article:2109293pubmed:authorsCompleteYlld:pubmed
pubmed-article:2109293pubmed:pagination795-9lld:pubmed
pubmed-article:2109293pubmed:dateRevised2009-10-26lld:pubmed
pubmed-article:2109293pubmed:meshHeadingpubmed-meshheading:2109293-...lld:pubmed
pubmed-article:2109293pubmed:meshHeadingpubmed-meshheading:2109293-...lld:pubmed
pubmed-article:2109293pubmed:meshHeadingpubmed-meshheading:2109293-...lld:pubmed
pubmed-article:2109293pubmed:meshHeadingpubmed-meshheading:2109293-...lld:pubmed
pubmed-article:2109293pubmed:meshHeadingpubmed-meshheading:2109293-...lld:pubmed
pubmed-article:2109293pubmed:meshHeadingpubmed-meshheading:2109293-...lld:pubmed
pubmed-article:2109293pubmed:meshHeadingpubmed-meshheading:2109293-...lld:pubmed
pubmed-article:2109293pubmed:meshHeadingpubmed-meshheading:2109293-...lld:pubmed
pubmed-article:2109293pubmed:meshHeadingpubmed-meshheading:2109293-...lld:pubmed
pubmed-article:2109293pubmed:meshHeadingpubmed-meshheading:2109293-...lld:pubmed
pubmed-article:2109293pubmed:meshHeadingpubmed-meshheading:2109293-...lld:pubmed
pubmed-article:2109293pubmed:meshHeadingpubmed-meshheading:2109293-...lld:pubmed
pubmed-article:2109293pubmed:meshHeadingpubmed-meshheading:2109293-...lld:pubmed
pubmed-article:2109293pubmed:meshHeadingpubmed-meshheading:2109293-...lld:pubmed
pubmed-article:2109293pubmed:year1990lld:pubmed
pubmed-article:2109293pubmed:articleTitleEvidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin.lld:pubmed
pubmed-article:2109293pubmed:affiliationDepartment of Obstetrics and Gynecology, Yale School of Medicine, New Haven, Connecticut.lld:pubmed
pubmed-article:2109293pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2109293pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2109293lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2109293lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2109293lld:pubmed